G57321FI
| Organisms | Evidence |
|---|---|
| Fasciola hepatica (liver fluke) | |
| Toxocara canis (dog roundworm) | |
| Echinococcus granulosus | |
| Oryctolagus cuniculus (rabbit) | |
| Ovis aries (sheep) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
| B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
| ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
| ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| B3GNT2 | UDP-GlcNAc |
|
[alpha]1-OBn | |
| GCNT4 | UDP-GlcNAc |
|
||
| GCNT1 | UDP-GlcNAc |
|
[alpha]-1-p-nitrophenyl | |
| A4GNT | UDP-GlcNAc |
|
[alpha]pNP | |
| GCNT3 | UDP-GlcNAc |
|
[alpha]-1-p-nitrophenyl |
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| Q12929 | Epidermal growth factor receptor kinase substrate 8 | ||
| Q13145 | BMP and activin membrane-bound inhibitor homolog | ||
| Q13201 | Multimerin-1 | ||
| Q13214 | Semaphorin-3B | ||
| Q13217 | DnaJ homolog subfamily C member 3 | ||
| Q13261 | Interleukin-15 receptor subunit alpha | ||
| Q13286 | Battenin | ||
| Q13308 | Inactive tyrosine-protein kinase 7 | ||
| Q13433 | Zinc transporter ZIP6 | ||
| Q13438 | Protein OS-9 |
| Pathway Name | Organism |
|---|---|
| E.coli O101 | Escherichia coli |
| E.coli O103 | Escherichia coli |
| E.coli O107 | Escherichia coli |
| E.coli O112ab | Escherichia coli |
| E.coli O112ac | Escherichia coli |
| E.coli O116 | Escherichia coli |
| E.coli O117 | Escherichia coli |
| E.coli O125ab | Escherichia coli |
| E.coli O127 | Escherichia coli |
| E.coli O128ab-H27 | Escherichia coli |
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 32081641 | Deficiency of O-linked-glycosylation regulates activation of T cells and aggravates Concanavalin A-induced liver injury | Hao X | 2020 Mar 30 |
|
| 32096313 | Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy participants | Deng Y | 2020 Mar 18 |
|
| 32170309 | Chimeric siRNAs with chemically modified pentofuranose and hexopyranose nucleotides: altritol-nucleotide (ANA) containing GalNAc–siRNA conjugates: in vitro and in vivo RNAi activity and resistance to 5′-exonuclease | Kumar P | 2020 Mar 14 |
|
| 31994716 | Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid, Givosiran, in Patients With Acute Hepatic Porphyria | Agarwal S | 2020 Mar 07 |
|
| 32134930 | Reduced expression of a rhomboid protease, EhROM1, correlates with changes in the submembrane distribution and size of the Gal/GalNAc lectin subunits in the human protozoan parasite, Entamoeba histolytica | Welter BH | 2020 Mar 05 |
|
| 32062176 | Cellular uptake of N-acetyl-d-galactosamine-, N-acetyl-d-glucosamine- and d-mannose-containing fluorescent glycoconjugates investigated by liver intravital microscopy | Maklakova SY | 2020 Mar |
|
| 32561705 | Therapeutic siRNA: state of the art | Hu B | 2020 Jun 19 |
|
| 32521139 | Givosiran — Running RNA Interference to Fight Porphyria Attacks | Gonzalez-Aseguinolaza G | 2020 Jun 11 |
|
| 32521132 | Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria | Balwani M | 2020 Jun 11 |
|
| 32145269 | Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-d-galactosamine/asialoglycoprotein receptor pathway | Sato Y | 2020 Jun 10 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025